Department of Biochemistry, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre (UKMMC), Kuala Lumpur, Malaysia.
Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre (UKMMC), Kuala Lumpur, Malaysia.
Pharm Biol. 2021 Dec;59(1):1203-1215. doi: 10.1080/13880209.2021.1970199.
(Lour.) Merr. (Asteraceae) has been reported to have various pharmacological activities including anti-inflammatory effects.
This study sought to determine whether (GP) could improve vascular reactivity by suppressing inflammation in postmenopausal rats fed with five-times heated palm oil (5HPO) diet.
Forty-eight female Sprague-Dawley rats were randomly divided into sham [non-ovariectomized; grouped as control, GP extracts (250 and 500 mg/kg), atorvastatin (ATV, 10 mg/kg)] and postmenopausal (PM) groups [ovariectomized rats fed with 5HPO; grouped as PM, GP extracts (250 and 500 mg/kg) and ATV (10 mg/kg)]. Each group ( = 6) was either supplemented with GP extract or ATV orally once daily for 6 months.
In comparison with the untreated PM group, 250 and 500 mg/kg GP supplementation to PM groups reduced the systolic blood pressure (103 ± 2.7, 86 ± 2.4 vs. 156 ± 7.83 mmHg, < 0.05), intima-media thickness (101.28 ± 3.4, 93.91 ± 2.93 vs. 143.78 ± 3.31 µM), vasoconstriction percentage induced by phenylephrine (102.5%, 88.3%, vs. 51.8%), sICAM-1 (0.49, 0.26 vs. 0.56 pg/mL) and sVCAM-1 (0.39, 0.25 vs. 0.45 pg/mL). GP extract supplementation increased vasorelaxation percentage induced by acetylcholine (78.4% vs. 47.3%) and sodium nitroprusside (84.2% vs. 53.7%), increased changes in plasma nitric oxide level (1.25%, 1.31% vs. 1.9%), and suppressed the elevation of TNF-α (0.39 vs. 1.02 pg/mL), IL-6 (0.43 vs. 0.77 pg/mL) and CRP (0.29 vs. 0.69 ng/mL) in the PM groups.
GP extract might improve vascular dysfunction by suppressing the inflammatory response, consequently preventing blood pressure elevation.
(Lour.)Merr.(菊科)已被报道具有多种药理活性,包括抗炎作用。
本研究旨在确定(GP)是否可以通过抑制接受五次加热棕榈油(5HPO)饮食的绝经后大鼠的炎症来改善血管反应性。
48 只雌性 Sprague-Dawley 大鼠随机分为假手术[非卵巢切除术;分为对照组、GP 提取物(250 和 500mg/kg)、阿托伐他汀(ATV,10mg/kg)]和绝经后(PM)组[卵巢切除术大鼠喂食 5HPO;分为 PM 组、GP 提取物(250 和 500mg/kg)和 ATV(10mg/kg)]。每组(n=6)每天口服补充 GP 提取物或 ATV 一次,持续 6 个月。
与未经治疗的 PM 组相比,250 和 500mg/kg GP 补充 PM 组降低了收缩压(103±2.7、86±2.4 与 156±7.83mmHg,<0.05)、内膜中层厚度(101.28±3.4、93.91±2.93 与 143.78±3.31μm)、苯肾上腺素诱导的血管收缩百分比(102.5%、88.3%,与 51.8%)、sICAM-1(0.49、0.26 与 0.56pg/mL)和 sVCAM-1(0.39、0.25 与 0.45pg/mL)。GP 提取物补充增加了乙酰胆碱诱导的血管舒张百分比(78.4%比 47.3%)和硝普钠诱导的血管舒张百分比(84.2%比 53.7%),增加了血浆一氧化氮水平的变化(1.25%、1.31%与 1.9%),并抑制了 PM 组 TNF-α(0.39 与 1.02pg/mL)、IL-6(0.43 与 0.77pg/mL)和 CRP(0.29 与 0.69ng/mL)的升高。
GP 提取物可能通过抑制炎症反应改善血管功能障碍,从而防止血压升高。